01 · Signal loss
Attribution broke, and most teams never replaced it
Privacy rules and platform changes hide an estimated 30 to 40 percent of trackable conversions. Planning still runs on a number everyone knows is wrong.
Optimal Intelligence
We strengthen the measurement and decisioning you already have, then apply the right mix of human and artificial intelligence. Built for complex customer journeys and tightly governed data.
Why this exists
In our experience, the gap sits underneath the models: in the measurement, data, and decision rights they depend on.
Diagnosis
None of them are about the model. All of them are decided before a line of code is written.
01 · Signal loss
Privacy rules and platform changes hide an estimated 30 to 40 percent of trackable conversions. Planning still runs on a number everyone knows is wrong.
02 · Compounding error
An autonomous optimizer pointed at a broken signal spends confidently in the wrong direction, at machine speed.
03 · Commoditization
Mix modeling is open source. The hard parts are the input data, the experiments that validate it, and finance accepting the answer.
04 · Regulation
Consent, data provenance, and medical and legal review decide what a model may do. Retrofitting them costs quarters.
Signal loss estimate: industry sources, Journify, 2026 and Open Future Forum, citing IAB State of Data 2026.
What we do
Measurement first, applied AI last, all on your existing data, AI, and marketing technology. Not every solution requires AI.
01
Mix modeling and experiments finance will sign off on.
02
Models that decide who gets what, governed and explainable.
03
AI in the daily marketing workflow, where it earns its place.
04
Roadmaps your stakeholders agree to, built on your stack.
Industries
Consent, data provenance, and compliance review shape what can be measured, modeled, and activated. We design for them from day one.
Our competitive advantage
Born in life sciences, pharma, and medical practices, we bring their regulatory rigor to every industry we serve.
It starts with understanding your customers: their journey from awareness to advocacy, and where to reach them with the right message at the right time. That is what compounds revenue and brand equity.
HCP, patient, and medical affairs, late phase to patent expiry. Rare disease and oncology specialists.
Aesthetics and plastic surgery: lower marketing costs, more new patients, higher lifetime value.
Marketing, sales, and dealer services across OEM, regional, and dealer levels.
Conservative supply and capital planning for growers and lenders. AI-forward retail.
Boutique and established brands scaling up or preparing for private equity or acquisition.
For investors. Data, analytics, and AI diligence on acquisition targets before the bid, and the remediation roadmap after close.
See the case studySelected work
Four engagements, described without naming clients.
How we engage
Starting fresh? Begin with the audit. AI already in production? Begin with course correction. We work as an extension of your team, not a company you outsource to.
Get started
A first conversation is a working session, not a pitch. Bring the number you cannot currently defend and you will leave with a point of view on it, whether or not we work together.